161 related articles for article (PubMed ID: 2593244)
1. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
[TBL] [Abstract][Full Text] [Related]
2. Coagulant and fibrinolytic activities in the leukemic cell lysates.
Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
[TBL] [Abstract][Full Text] [Related]
3. [Plasminogen activator in leukemic cell homogenate].
Wada H; Ogasawara Z; Kumeda Y; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T
Rinsho Ketsueki; 1990 Nov; 31(11):1794-9. PubMed ID: 2287063
[TBL] [Abstract][Full Text] [Related]
4. [Effect of normal and leukemic leukocytes on blood coagulation and fibrinolysis].
Hiller E
Fortschr Med; 1978 Jun; 96(22):1181-4. PubMed ID: 658868
[TBL] [Abstract][Full Text] [Related]
5. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
6. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
Soma M; Maeda Y; Kasakura S; Yabe H
Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
Francis RB; Seyfert U
J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
[TBL] [Abstract][Full Text] [Related]
9. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
10. Elevated tissue factor levels in leukemic cell homogenate.
Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
[TBL] [Abstract][Full Text] [Related]
11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
13. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
14. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
[TBL] [Abstract][Full Text] [Related]
15. Recurrent venous thrombosis as the presenting manifestation of acute lymphocytic leukemia: leukemic cell procoagulant activity is not responsible for the hypercoagulable state.
Bilgrami S; Greenberg BR; Weinstein RE; Hair GA; Rickles FR
Med Pediatr Oncol; 1995 Jan; 24(1):40-5. PubMed ID: 7968791
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor (TF) and urokinase plasminogen activator receptor (uPAR) and bleeding complications in leukemic patients.
López-Pedrera C; Jardí M; del Mar Malagón M; Inglés-Esteve J; Dorado G; Torres A; Félez J; Velasco F
Thromb Haemost; 1997 Jan; 77(1):62-70. PubMed ID: 9031451
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
18. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation in acute leukemia.
Barbui T; Falanga A
Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
[TBL] [Abstract][Full Text] [Related]
20. [Effects of realgar on tissue factor expression of NB4 and MR2 cells].
Zhao XA; Liu SX
Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):553-6. PubMed ID: 15015339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
